NCT06487871View on ClinicalTrials.gov

A Study to Assess the Effect of Fucoidan on Prostate Health in Males With Benign Prostatic Hyperplasia

NACompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

August 5, 2024

Primary Completion Date

January 15, 2025

Study Completion Date

January 15, 2025

Conditions
Benign Prostatic Hyperplasia
Interventions
DIETARY_SUPPLEMENT

Fucoidan extracted from Undaria pinnatifida (UPF)

Two capsules to be taken after breakfast daily, with 200 ml glass of water for 90 days.

DIETARY_SUPPLEMENT

Placebo

Two capsules to be taken after breakfast daily, with 200 ml glass of water for 90 days.

Trial Locations (6)

141014

Rising Medicare Hospital Name of, Pune

390012

Sarjanam Hospital, Vadodara

410506

Pawana Hospital, Pune

411045

Bhalerao Clinics, Pune

440025

NKP Salve Institute of Medical Science and Research Centre and Lata Mangeshkar Hospital, Nagpur

7060924809

Jaipur National University of Medical Science and Research Centre Name of, Jaipur

All Listed Sponsors
lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY

NCT06487871 - A Study to Assess the Effect of Fucoidan on Prostate Health in Males With Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter